Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Suspected Hepatically Localized Granulomatosis with Polyangiitis.

Yamamoto T, Ryuzaki H, Kobayashi S, Ohshiro S, Ogawa M, Tanaka N, Gotoda T, Moriyama M, Kinukawa N, Sugitani M, Notohara K.

Intern Med. 2018 Jun 1;57(11):1583-1590. doi: 10.2169/internalmedicine.9724-17. Epub 2018 Feb 9.

2.

Autoimmune liver disease-related autoantibodies in patients with biliary atresia.

Pang SY, Dai YM, Zhang RZ, Chen YH, Peng XF, Fu J, Chen ZR, Liu YF, Yang LY, Wen Z, Yu JK, Liu HY.

World J Gastroenterol. 2018 Jan 21;24(3):387-396. doi: 10.3748/wjg.v24.i3.387.

3.

Serology in autoimmune hepatitis: A clinical-practice approach.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.

Eur J Intern Med. 2018 Feb;48:35-43. doi: 10.1016/j.ejim.2017.10.006. Epub 2017 Oct 19. Review.

PMID:
29056396
4.

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH.

Liver Int. 2017 Mar;37(3):458-465. doi: 10.1111/liv.13238. Epub 2016 Sep 13.

PMID:
27558072
5.

Scleroderma and liver disease: a case of an association with primary sclerosing cholangitis.

Zampetti A, Rinninella E, Manna R, Franceschi F.

Scand J Rheumatol. 2016 Jul;45(4):334-5. doi: 10.3109/03009742.2015.1114667. Epub 2015 Dec 21. No abstract available.

PMID:
26690847
6.

Autoantibodies in autoimmune liver diseases.

Sener AG.

APMIS. 2015 Nov;123(11):915-9. doi: 10.1111/apm.12442. Epub 2015 Sep 11. Review.

PMID:
26359647
7.

PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, Kaplan GG, Lindkvist B, Hirschfield GM, Milkiewicz P, Cheung A, Janssen HL, Fritzler MJ.

PLoS One. 2014 Nov 14;9(11):e112877. doi: 10.1371/journal.pone.0112877. eCollection 2014.

8.

Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.

Sowa M, Grossmann K, Knütter I, Hiemann R, Röber N, Anderer U, Csernok E, Bogdanos DP, Borghi MO, Meroni PL, Schierack P, Reinhold D, Conrad K, Roggenbuck D.

PLoS One. 2014 Sep 16;9(9):e107743. doi: 10.1371/journal.pone.0107743. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0120626. PLoS One. 2015;10(5):e0127933.

9.

Diagnosis and classification of ulcerative colitis.

Conrad K, Roggenbuck D, Laass MW.

Autoimmun Rev. 2014 Apr-May;13(4-5):463-6. doi: 10.1016/j.autrev.2014.01.028. Epub 2014 Jan 11. Review.

PMID:
24424198
10.

Clinical significance of autoantibodies in autoimmune hepatitis.

Liberal R, Mieli-Vergani G, Vergani D.

J Autoimmun. 2013 Oct;46:17-24. doi: 10.1016/j.jaut.2013.08.001. Epub 2013 Sep 7. Review.

PMID:
24016388
11.

Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.

Lenzen H, Weismüller TJ, Negm AA, Wlecke J, Loges S, Strassburg CP, Manns MP, Lankisch TO.

Scand J Gastroenterol. 2013 Oct;48(10):1205-12. doi: 10.3109/00365521.2013.825313. Epub 2013 Aug 19.

PMID:
23957616
12.

Role of international criteria in the diagnosis of autoimmune hepatitis.

Abdollahi MR, Somi MH, Faraji E.

World J Gastroenterol. 2013 Jun 21;19(23):3629-33. doi: 10.3748/wjg.v19.i23.3629.

13.

Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.

Achenza MI, Meda F, Brunetta E, Selmi C.

Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):717-29. doi: 10.1586/egh.12.58. Review.

PMID:
23237257
14.

Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis.

Deniziaut G, Ballot E, Johanet C.

Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):105-7. doi: 10.1016/j.clinre.2012.07.008. Epub 2012 Sep 19. No abstract available.

PMID:
22998811
15.

Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature.

Larsen EP, Bayat A, Vyberg M.

Diagn Pathol. 2012 Aug 14;7:100. doi: 10.1186/1746-1596-7-100. Review.

16.

Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.

Dobric S, Popovic D, Nikolic M, Andrejevic S, Spuran M, Bonaci-Nikolic B.

Clin Chem Lab Med. 2011 Nov 23;50(3):503-9. doi: 10.1515/CCLM.2011.797.

PMID:
22107137
17.

[Diagnostic value of antineutophil cytoplasmic antibodies].

Zak-Gołab A, Hrycek A, Holecki M, Chudek J.

Wiad Lek. 2011;64(1):37-42. Review. Polish.

PMID:
21812362
18.

IgG4-related systemic disease in a Native American man.

Patel SM, Szostek JH.

Intern Med. 2011;50(8):931-4. Epub 2011 Apr 15. Review.

19.

Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders.

Op De Beéck K, Van den Bergh K, Vermeire S, Decock S, Derua R, Waelkens E, Rutgeerts P, Nevens F, Bossuyt X.

Gut. 2011 Nov;60(11):1601-2. doi: 10.1136/gut.2010.222646. Epub 2010 Dec 15. No abstract available.

PMID:
21159894
20.

Discrimination of autoimmune hepatitis: autoantibody typing and beyond.

Krawitt EL.

J Gastroenterol. 2011 Jan;46 Suppl 1:39-41. doi: 10.1007/s00535-010-0324-3. Epub 2010 Sep 23.

PMID:
20862497

Supplemental Content

Loading ...
Support Center